Target intelligence / Profile preview

Fast skeletal muscle troponin-tropomyosin complex (fsTn-Tm)

Target
fsTn-Tm
Molecular classification
Protein complex, Regulatory protein, Myofilament protein
01

Overview

The fast skeletal muscle troponin-tropomyosin complex is a critical regulatory assembly located on the thin filaments of fast-twitch (Type II) muscle fibers. It consists of three troponin subunits—troponin C (TnC), troponin I (TnI), and troponin T (TnT)—alongside tropomyosin (UniProt: P02585). In the resting state, the complex inhibits the interaction between actin and myosin; upon calcium binding to TnC, a conformational change occurs that shifts tropomyosin, exposing myosin-binding sites on actin and initiating muscle contraction (PubMed: 21975163). This complex serves as a therapeutic target for conditions characterized by muscle weakness or fatigue, such as amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA) (PubMed: 33403334). Pharmacological agents known as fast skeletal muscle troponin activators (FSTAs), such as tirasemtiv and reldesemtiv, bind to the complex to increase its sensitivity to calcium. By slowing the dissociation of calcium from TnC, these drugs enhance muscle force production during submaximal nerve stimulation, potentially improving physical function and respiratory capacity in patients with neuromuscular disorders (Cytokinetics, 2023). Clinical development has focused on leveraging this mechanism to provide functional benefits to patients with compromised motor neuron activity.

Other names
Fast skeletal troponin complexfsTn complexTroponin-tropomyosin regulatory complexFast skeletal muscle troponin
02

Mechanism of action

Fast skeletal muscle troponin activation; the drugs bind to the troponin complex and increase its sensitivity to calcium by slowing the rate of calcium dissociation from troponin C, thereby enhancing muscle force production at submaximal nerve stimulation (PubMed: 21975163).

03

Biological functions

Muscle contractionCalcium-mediated regulation of muscle contractionActin-myosin interaction regulation
04

Disease associations

Amyotrophic lateral sclerosisSpinal muscular atrophyMyasthenia gravisChronic obstructive pulmonary diseaseSarcopenia
05

Safety considerations

DizzinessNauseaFatigueHeadacheDrug-drug interactions (e.g., with theophylline)
06

Interacting drugs

Tirasemtiv

1 more in the full profile.

07

Biomarkers

Slow Vital Capacity (SVC)Hand-held dynamometry (HHD)6-minute walk test (6MWT)ALS Functional Rating Scale-Revised (ALSFRS-R)

Beyond the preview

Go deeper on Fast skeletal muscle troponin-tropomyosin complex (fsTn-Tm).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fast skeletal muscle troponin-tropomyosin complex (fsTn-Tm).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call